By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Addrenex Pharmaceuticals (Acquired by Sciele Pharma) 

Press releases archived for reference only.

Morrisville  North Carolina    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Sciele Pharma, Inc. (SCRX), a Shionogi & Co., Ltd. Company, to Acquire Addrenex Pharmaceuticals, a U.S. Specialty Pharmaceutical Company 11/16/2009 10:36:14 AM
Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma 8/5/2009 9:31:00 AM
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy 5/13/2009 8:34:30 AM
Sciele Pharma, Inc. (SCRX) and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD 4/23/2009 12:10:00 PM
Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication 4/23/2009 9:13:10 AM
Sciele Pharma, Inc. (SCRX) Announces That Addrenex Pharmaceuticals Initiates Phase II Clinical Trial of ADX415 for the Treatment of Hypertension 10/23/2008 2:02:21 PM
Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415 10/23/2008 9:56:05 AM
Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD 9/11/2008 6:34:05 AM
Sciele Pharma, Inc. (SCRX) and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD 9/10/2008 12:28:06 PM
Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 8/20/2008 7:29:45 AM
12
//-->